Bassil Dahiyat is the founder of Xencor. Xencor has raised $65M in total funding. Latest round: IPO. Based in Monrovia, CA, USA.
Bassil Dahiyat is a co-founder of Xencor, a biopharmaceutical company specializing in protein therapeutics. He transitioned from CEO to Chief Scientific Officer in 2003 and later returned as CEO. Under his leadership, Xencor, now publicly traded, has grown to be valued at approximately $1.8 billion with numerous drugs in development.
Full founder directory · Investor directory · Company funding database · Fundraising library